These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

583 related articles for article (PubMed ID: 11724655)

  • 1. The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56).
    Stevens RJ; Kothari V; Adler AI; Stratton IM;
    Clin Sci (Lond); 2001 Dec; 101(6):671-9. PubMed ID: 11724655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of the Framingham cardiovascular risk equation and the UKPDS risk engine for coronary heart disease in newly diagnosed Type 2 diabetes: results from a United Kingdom study.
    Guzder RN; Gatling W; Mullee MA; Mehta RL; Byrne CD
    Diabet Med; 2005 May; 22(5):554-62. PubMed ID: 15842509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of 10-year coronary heart disease risk in Caribbean type 2 diabetic patients using the UKPDS risk engine.
    Ezenwaka CE; Nwagbara E; Seales D; Okali F; Hussaini S; Raja B; Jones-LeCointe A; Sell H; Avci H; Eckel J
    Int J Cardiol; 2009 Mar; 132(3):348-53. PubMed ID: 18191239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pen-and-paper coronary risk estimator for office use with patients with type 2 diabetes.
    Christianson TJ; Bryant SC; Weymiller AJ; Smith SA; Montori VM
    Mayo Clin Proc; 2006 May; 81(5):632-6. PubMed ID: 16706261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronary heart disease risk assessment in diabetes mellitus: comparison of UKPDS risk engine with Framingham risk assessment function and its clinical implications.
    Song SH; Brown PM
    Diabet Med; 2004 Mar; 21(3):238-45. PubMed ID: 15008833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Derivation and validation of a prediction score for major coronary heart disease events in a U.K. type 2 diabetic population.
    Donnan PT; Donnelly L; New JP; Morris AD
    Diabetes Care; 2006 Jun; 29(6):1231-6. PubMed ID: 16732001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the Framingham and United Kingdom Prospective Diabetes Study cardiovascular risk equations in Australian patients with type 2 diabetes from the Fremantle Diabetes Study.
    Davis WA; Colagiuri S; Davis TM
    Med J Aust; 2009 Feb; 190(4):180-4. PubMed ID: 19220181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of a total coronary heart disease risk score in type 2 diabetes mellitus.
    Yang X; So WY; Kong AP; Ma RC; Ko GT; Ho CS; Lam CW; Cockram CS; Chan JC; Tong PC
    Am J Cardiol; 2008 Mar; 101(5):596-601. PubMed ID: 18308005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recalculation of cardiovascular risk score as a surrogate marker of change in clinical care of diabetes patients: the Alphabet POEM project (Practice Of Evidence-based Medicine).
    Lee JD; Morrissey JR; Patel V;
    Curr Med Res Opin; 2004 May; 20(5):765-72. PubMed ID: 15140344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting macro- and microvascular complications in type 2 diabetes: the Japan Diabetes Complications Study/the Japanese Elderly Diabetes Intervention Trial risk engine.
    Tanaka S; Tanaka S; Iimuro S; Yamashita H; Katayama S; Akanuma Y; Yamada N; Araki A; Ito H; Sone H; Ohashi Y; ;
    Diabetes Care; 2013 May; 36(5):1193-9. PubMed ID: 23404305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preventable coronary heart disease events from control of cardiovascular risk factors in US adults with diabetes (projections from utilizing the UKPDS risk engine).
    Wong ND; Patao C; Malik S; Iloeje U
    Am J Cardiol; 2014 Apr; 113(8):1356-61. PubMed ID: 24581920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of coronary heart disease risk in a general, pre-diabetic, and diabetic population during 10 years of follow-up: accuracy of the Framingham, SCORE, and UKPDS risk functions: The Hoorn Study.
    van der Heijden AA; Ortegon MM; Niessen LW; Nijpels G; Dekker JM
    Diabetes Care; 2009 Nov; 32(11):2094-8. PubMed ID: 19875606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skin autofluorescence provides additional information to the UK Prospective Diabetes Study (UKPDS) risk score for the estimation of cardiovascular prognosis in type 2 diabetes mellitus.
    Lutgers HL; Gerrits EG; Graaff R; Links TP; Sluiter WJ; Gans RO; Bilo HJ; Smit AJ
    Diabetologia; 2009 May; 52(5):789-97. PubMed ID: 19274450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of three different methods of assessing cardiovascular disease risk in New Zealanders with Type 2 diabetes mellitus.
    Metcalf PA; Wells S; Scragg RK; Jackson R
    N Z Med J; 2008 Sep; 121(1281):49-57. PubMed ID: 18797484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex-specific differences in metabolic control, cardiovascular risk, and interventions in patients with type 2 diabetes mellitus.
    Kautzky-Willer A; Kamyar MR; Gerhat D; Handisurya A; Stemer G; Hudson S; Luger A; Lemmens-Gruber R
    Gend Med; 2010 Dec; 7(6):571-83. PubMed ID: 21195357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of coronary artery disease in type 2 diabetes and the delivery of care consistent with the chronic care model in primary care settings: a STARNet study.
    Parchman ML; Zeber JE; Romero RR; Pugh JA
    Med Care; 2007 Dec; 45(12):1129-34. PubMed ID: 18007162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ankle brachial pressure index usefulness as predictor factor for coronary heart disease in diabetic patients.
    Filippella M; Lillaz E; Ciccarelli A; Giardina S; Massimetti E; Navaretta F; Antico A; Veronesi M; Lombardi G; Colao A; Ghigo E; Benso A; Doveri G
    J Endocrinol Invest; 2007 Oct; 30(9):721-5. PubMed ID: 17993762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimating risk factor progression equations for the UKPDS Outcomes Model 2 (UKPDS 90).
    Leal J; Alva M; Gregory V; Hayes A; Mihaylova B; Gray AM; Holman RR; Clarke P
    Diabet Med; 2021 Oct; 38(10):e14656. PubMed ID: 34297424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time-varying risk of microvascular complications in latent autoimmune diabetes of adulthood compared with type 2 diabetes in adults: a post-hoc analysis of the UK Prospective Diabetes Study 30-year follow-up data (UKPDS 86).
    Maddaloni E; Coleman RL; Agbaje O; Buzzetti R; Holman RR
    Lancet Diabetes Endocrinol; 2020 Mar; 8(3):206-215. PubMed ID: 32032540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-monitoring of blood glucose improved glycemic control and the 10-year coronary heart disease risk profile of female type 2 diabetes patients in Trinidad and Tobago.
    Ezenwaka CE; Dimgba A; Okali F; Skinner T; Extavour R; Rodriguez M; Jones-LeCointe A
    Niger J Clin Pract; 2011; 14(1):1-5. PubMed ID: 21493982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.